Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Growth in China's service sector eases in June - Caixin

(Sharecast News) - Growth in China's services sector eased in June, according to data released on Thursday. Caixin's services purchasing managers' index fell to 50.6 from 51.1 in May. This was below expectations for a reading of 51 and marked the slowest growth in nine months.

A reading above 50 indicates expansion, while a reading below signals contraction.

The data showed that rates of both business activity and new order growth eased compared with May amid another reduction in new export business.

Wang Zhe, senior economist at Caixin Insight Group, said: "Expansion in supply and demand slowed. Despite businesses' efforts to pursue new customers, growth in demand was limited. In June, business activity and total new orders both grew for the 30th consecutive month but at slower clips than the previous month. External uncertainties had a greater negative impact on service exports, with new export business continuing to decline, doing so at the sharpest pace since December 2022.

"Employment declined. In June, the corresponding gauge was in contractionary territory for the third time out of the past four months. Service providers remained cautious about hiring as they continued to prioritize controlling costs. The shrinking workforce led to a moderate increase in backlogs of work, which grew at the fastest pace in a year."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.